U.S. Pharma Stock News

NYSE:GFR
NYSE:GFROil and Gas

Greenfire Resources (NYSE:GFR) Quarterly Loss Challenges Bullish Margin Improvement Narrative

Greenfire Resources (NYSE:GFR) has just posted its FY 2025 third quarter numbers, with revenue of C$136.6 million and a basic EPS loss of C$0.12, set against trailing twelve month revenue of C$655.8 million and basic EPS of C$1.93. Over recent periods, the company has seen quarterly revenue move from C$209.5 million in Q2 2024 to C$201.8 million in Q4 2024, then to C$176.8 million in Q1 2025 and C$140.6 million in Q2 2025, while basic EPS shifted from C$0.45 in Q2 2024 to C$1.13 in Q4 2024,...
NYSE:SRFM
NYSE:SRFMAirlines

Surf Air Mobility (SRFM) Quarterly Loss Of US$27 Million Tests Long Term Growth Narrative

Surf Air Mobility (SRFM) just posted its FY 2025 third quarter numbers, with revenue at US$29.2 million and a basic EPS loss of US$0.64, while trailing twelve month figures show revenue of US$108.2 million and a basic EPS loss of US$3.00. The company has seen quarterly revenue range between US$23.5 million and US$32.4 million across the last six reported periods, with basic EPS moving between a loss of US$24.20 and a small profit of US$0.08. This sets up a story where investors are weighing...
NYSE:EGY
NYSE:EGYOil and Gas

VAALCO Energy Q4 Loss And TTM Turn To Red Test Bullish Profitability Narratives

VAALCO Energy (EGY) closed FY 2025 with Q4 revenue of US$91.0 million and a basic EPS loss of US$0.56, compared with Q4 FY 2024 revenue of US$121.7 million and basic EPS of US$0.11. Over the past year, the trailing twelve month figures moved from revenue of US$479.0 million and basic EPS of US$0.56 at Q4 FY 2024 to revenue of US$359.3 million and a basic EPS loss of US$0.40 by Q4 FY 2025. This sets a challenging backdrop for margins and profitability as investors weigh the company’s...
NasdaqCM:VUZI
NasdaqCM:VUZIElectronic

Vuzix (VUZI) Quarterly Losses Near US$7 Million Reinforce Bearish Cash Burn Narrative

Vuzix (VUZI) has put out its latest FY 2025 numbers with Q3 revenue of about US$1.2 million and a basic EPS loss of US$0.10, alongside a trailing 12 month EPS loss of roughly US$0.49 on revenue of US$5.3 million. Over recent quarters the company has seen revenue move between about US$1.1 million and US$1.6 million while quarterly basic EPS losses have ranged from roughly US$0.10 to US$0.16. As a result, investors may focus less on top line swings and more on how much cash is being burned to...
NasdaqGS:ULTA
NasdaqGS:ULTASpecialty Retail

Ulta Beauty (ULTA) Margin Compression Challenges Bullish Growth Narratives After FY 2026 Results

Ulta Beauty (ULTA) has capped FY 2026 with fourth quarter revenue of US$3.9b and basic EPS of US$8.05, alongside net income of US$356.7m, while full year trailing revenue sits at US$12.4b and EPS at US$25.72. The company has seen quarterly revenue move from US$3.5b and EPS of US$8.50 in Q4 FY 2025 to US$3.9b and EPS of US$8.05 in Q4 FY 2026, with comparable sales for the latest quarter at 5.8% and trailing twelve month same store sales growth at 5.4%. With net income over the last twelve...
NasdaqGS:CALM
NasdaqGS:CALMFood

How Analyst Expectations For a Revenue Drop at Cal-Maine (CALM) Have Changed Its Investment Story

Cal-Maine Foods, Inc. recently highlighted its position as the largest U.S. egg producer and scheduled the release of its fiscal 2026 third-quarter results, alongside a management webcast that has now taken place. At the same time, a sharp contrast has emerged between the company’s historically strong revenue growth and analysts’ expectations for a very large revenue decline over the next year. We’ll now examine how concerns about a very large potential revenue drop interact with Cal-Maine...
NYSE:AXR
NYSE:AXRReal Estate

AMREP (AXR) Net Margin Strengthens To 22.9% And Tests Bearish Earnings Narratives

AMREP (AXR) has released its Q3 2026 scorecard, with Q2 fiscal 2026 revenue of US$9.4 million and basic EPS of US$0.22, alongside trailing twelve month revenue of US$45.9 million and EPS of US$1.97 as investors weigh the latest move in margins. Over the past six reported quarters, the company has seen quarterly revenue range between US$7.5 million and US$19.1 million, while basic EPS has moved between US$0.13 and US$0.88. This provides a clear data trail on how the business has been...
NYSE:KLC
NYSE:KLCConsumer Services

KinderCare Learning Companies (KLC) Quarterly Profit But TTM Losses Undercut Bullish Narratives

KinderCare Learning Companies (KLC) has put up a mixed set of FY 2025 numbers, with third quarter revenue at US$676.8 million and basic EPS of US$0.04, against a trailing twelve month picture that still shows a loss with EPS of US$0.59 on revenue of about US$2.7 billion. Over recent quarters the company has seen revenue move between US$668.2 million and US$700.1 million, while basic EPS ranged from US$0.18 to US$0.33. The latest print now sits at the lower end of that earnings range, so...
NasdaqGS:PAYP
NasdaqGS:PAYPDiversified Financial

A Look At PayPay (PAYP) Valuation After Its High Profile IPO And Strong First Trading Session

PayPay (PAYP) has just come to market with a high profile US$879.8m IPO of American Depositary Shares, followed immediately by a roughly US$199.0m shelf registration tied to an ESOP related offering. See our latest analysis for PayPay. Coming straight after a strong first trading session and the ESOP related shelf registration, PayPay’s 1 day share price return of 16.41% and year to date share price return of 32.12% suggest early momentum and rising risk appetite around the stock’s story. If...
NYSE:BSX
NYSE:BSXMedical Equipment

Electrophysiology Lawsuits and China Push Might Change The Case For Investing In Boston Scientific (BSX)

In early 2026, multiple law firms launched or expanded securities class action lawsuits alleging Boston Scientific misled investors about the performance and sustainability of growth in its U.S. Electrophysiology segment, following weaker-than-expected 2025 results and cautious 2026 guidance. At the same time, Boston Scientific moved ahead with clinical expansion efforts, planning a new China registry for its ENROUTE neuroprotection system and Carotid WALLSTENT to build real-world evidence...
NYSE:SUNB
NYSE:SUNBTrade Distributors

Sunbelt Rentals Holdings Q3 Margin Compression Tests Bullish Growth Narratives

Sunbelt Rentals Holdings (SUNB) has put fresh numbers on the board for Q3 2026, reporting revenue of US$2.6b and basic EPS of US$0.69, with net income excluding extra items at US$290m. Over recent quarters the company has seen revenue move from US$2.6b in Q3 2025 to US$2.5b in Q4 2025, then to US$2.8b in Q1 2026 and US$3.0b in Q2 2026. Quarterly EPS ranged from US$0.71 to US$1.11 over that stretch, setting up Q3’s EPS of US$0.69 in a context of shifting profitability. With net profit margin...
NasdaqGS:SNEX
NasdaqGS:SNEXCapital Markets

StoneX Group Board Refresh Sparks Questions On Valuation And Share Price

StoneX Group (NasdaqGS:SNEX) has elected John Radziwill as Chairman of the Board. Sean M. O'Connor has been appointed Executive Vice-Chairman following the latest shareholder and board meetings. These board-level changes follow the company’s annual governance cycle and signal a refreshed leadership structure. StoneX Group operates as a global financial services firm connecting clients to a wide range of markets, from commodities and foreign exchange to securities and clearing. For...
NasdaqCM:HNRG
NasdaqCM:HNRGRenewable Energy

Hallador Energy (HNRG) Profitability Turnaround To US$41.9 Million Tests Cautious Earnings Narratives

Hallador Energy (HNRG) just closed out FY 2025 with fourth quarter revenue of US$101.9 million and a small net loss of US$0.24 million, translating to a near flat basic EPS of a US$0.01 loss, against a trailing twelve month picture that shows revenue of US$469.5 million and net income of US$41.9 million, or basic EPS of US$0.98. Over recent quarters, revenue has moved from US$105.2 million in Q3 2024 to US$117.8 million in Q1 2025, US$102.9 million in Q2, US$146.8 million in Q3 and US$101.9...
NYSE:MAIN
NYSE:MAINCapital Markets

Is Main Street Capital (MAIN) Pricing Look Stretched After Recent Share Price Weakness

If you are wondering whether Main Street Capital's current share price offers good value or not, you are not alone. Many income focused investors are asking the same question right now. The stock most recently closed at US$54.89, with returns of 4.8% over 1 year but declines of 4.3% over 7 days, 10.9% over 30 days and 11.1% year to date. This may be reshaping how investors think about its risk and return profile. Recent company updates and sector commentary have kept Main Street Capital on...
NasdaqGS:TNXP
NasdaqGS:TNXPBiotechs

Tonix Pharmaceuticals Holding (TNXP) Q4 Loss Deepens Community Concerns Despite Revenue Progress

Tonix Pharmaceuticals Holding (TNXP) just closed out FY 2025 with fourth quarter revenue of US$5.39 million, Basic EPS of a US$3.98 loss, and a net loss excluding extra items of US$46.91 million, putting fresh numbers around a business that is still firmly in investment mode. The company has seen quarterly revenue move from US$2.58 million and Basic EPS of a US$9.77 loss in Q4 2024 to US$5.39 million and Basic EPS of a US$3.98 loss in Q4 2025, giving investors a clearer view of how sales and...
NYSE:CIA
NYSE:CIAInsurance

Citizens (CIA) Margin Compression Challenges Bullish Narratives After FY 2025 Earnings

Citizens (CIA) closed out FY 2025 with fourth quarter revenue of US$72.1 million and basic EPS of US$0.14, alongside net income of US$7.3 million, giving investors a fresh look at how its underwriting and fee streams are translating into bottom line results. The company has seen quarterly revenue move from US$63.5 million in Q4 2024 to US$72.1 million in Q4 2025, with basic EPS shifting from US$0.07 to US$0.14 over the same period. Trailing 12 month EPS across recent quarters has ranged from...
OTCPK:VXRT
OTCPK:VXRTBiotechs

Vaxart (VXRT) Revenue Surge To US$72.4 Million Tests Bearish Decline Narrative

Vaxart (VXRT) has reported another loss making quarter, with Q3 FY 2025 revenue of about US$72.4 million and a basic EPS loss of US$0.04, alongside trailing twelve month revenue of roughly US$148.2 million and a basic EPS loss of US$0.22. Over recent periods, the company has seen quarterly revenue move from US$4.9 million in Q3 FY 2024 to US$15.2 million in Q4 FY 2024, then to US$20.9 million in Q1 FY 2025 and US$39.7 million in Q2 FY 2025. Basic EPS losses have ranged from US$0.09 in Q2 FY...
NYSE:ASA
NYSE:ASACapital Markets

A Look At ASA Gold And Precious Metals (ASA) Valuation After CANSLIM Growth Stock Recognition

Why ASA Gold and Precious Metals (ASA) is back on growth investors’ radar ASA Gold and Precious Metals (ASA) has drawn fresh attention after being flagged as a potential CANSLIM growth name, supported by strong quarterly and annual earnings metrics, as well as a balance sheet with no debt. See our latest analysis for ASA Gold and Precious Metals. Even after a recent 7 day share price return of around an 11% decline and a 30 day share price return of about a 10% decline from the latest close...
NYSE:CDRE
NYSE:CDREAerospace & Defense

Cadre Holdings (CDRE) Valuation Check After Recent Share Price Weakness

Cadre Holdings: Recent Moves and Context for Investors Cadre Holdings (CDRE) has been under pressure recently, with the stock showing negative returns over the past week, month, and past 3 months. This may prompt investors to reassess expectations and risk tolerance. See our latest analysis for Cadre Holdings. Despite the recent pressure, the 1-year total shareholder return of a 5.1% decline contrasts with a 72.1% gain over three years. This suggests that short term momentum has faded while...
NYSE:FIS
NYSE:FISDiversified Financial

FIS Insider Buying And Mizuho Win Highlight Higher Value Banking Focus

Fidelity National Information Services (NYSE:FIS) CEO Stephanie Ferris recently bought additional company shares, increasing her personal stake. The company has been selected by Mizuho Financial Group to provide its Balance Sheet Manager solution for advanced balance sheet automation and regulatory support. For investors tracking NYSE:FIS, these developments come against a mixed share price backdrop, with the stock at $49.7 and showing a 24.3% decline year to date and a 28.1% decline over...
NasdaqGM:PAYO
NasdaqGM:PAYODiversified Financial

Assessing Payoneer Global (PAYO) After Steep Share Price Declines

If you are wondering whether Payoneer Global's share price offers good value right now, you are not alone. This article focuses squarely on what the current market price might be implying. Payoneer Global's share price closed at US$4.43, with returns of an 8.7% decline over 7 days, a 26.2% decline over 30 days, an 18.6% decline year to date, a 37.6% decline over 1 year, a 27.7% decline over 3 years and a 60.2% decline over 5 years. Recent coverage around Payoneer Global has focused on its...
NasdaqGS:ROST
NasdaqGS:ROSTSpecialty Retail

Is It Too Late To Consider Ross Stores (ROST) After A 72% One-Year Surge?

If you are wondering whether Ross Stores is still reasonably priced after its strong run, this article will walk through what the current share price might imply about value. The stock recently closed at US$209.84, with returns of 9.1% over the last 30 days and 72.4% over the past year. The 7-day return of a 2.3% decline shows that shorter term sentiment can look quite different to the longer trend. Recent coverage of Ross Stores has focused on its role as a large off price retailer and how...
NYSE:CRC
NYSE:CRCOil and Gas

Is It Time To Reassess California Resources (CRC) After Its Recent Share Price Swings?

If you are looking at California Resources and wondering whether the current share price reflects its true worth, you are not alone. The stock closed at US$61.47 recently, after a 5.1% decline over the last 7 days, an 8.3% gain over 30 days, and returns of 32.5% year to date and 45.6% over the last year. These moves have come as investors continue to track company specific developments and broader energy sector sentiment, with recent attention on how producers are positioning themselves...
NasdaqGS:MRTN
NasdaqGS:MRTNTransportation

Assessing Marten Transport (MRTN) Valuation After Recent Share Price Weakness

What Marten Transport’s recent performance might mean for investors Marten Transport (MRTN) has come onto investors’ radar after a period where the share price showed a 2.5% gain over the past day, in contrast with negative moves over the past week and month. See our latest analysis for Marten Transport. That 2.5% one day share price gain comes after a 14.2% 30 day share price decline and a 12.5% 1 year total shareholder return loss, which suggests recent momentum has been fading rather than...